Does TOPOTECAN Cause Central nervous system lesion? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Central nervous system lesion have been filed in association with TOPOTECAN (HYCAMTIN). This represents 0.3% of all adverse event reports for TOPOTECAN.
11
Reports of Central nervous system lesion with TOPOTECAN
0.3%
of all TOPOTECAN reports
6
Deaths
11
Hospitalizations
How Dangerous Is Central nervous system lesion From TOPOTECAN?
Of the 11 reports, 6 (54.5%) resulted in death, 11 (100.0%) required hospitalization.
Is Central nervous system lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOPOTECAN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TOPOTECAN Cause?
Febrile neutropenia (425)
Off label use (390)
Death (332)
Product use in unapproved indication (323)
Neutropenia (255)
Pyrexia (252)
Anaemia (242)
Malignant neoplasm progression (238)
Drug ineffective (216)
Disease progression (207)
What Other Drugs Cause Central nervous system lesion?
FINGOLIMOD (2,416)
DIMETHYL (1,152)
INTERFERON BETA-1A (978)
NATALIZUMAB (627)
DALFAMPRIDINE (561)
GLATIRAMER (492)
TERIFLUNOMIDE (315)
ADALIMUMAB (229)
OFATUMUMAB (185)
RITUXIMAB (151)
Which TOPOTECAN Alternatives Have Lower Central nervous system lesion Risk?
TOPOTECAN vs TOPOTECAN\TOPOTECAN
TOPOTECAN vs TOPROL
TOPOTECAN vs TOREMIFENE
TOPOTECAN vs TORIPALIMAB
TOPOTECAN vs TORSEMIDE